Ligand validation:4XPB

CLR: CHOLESTEROL

CLR is a Ligand Of Interest in 4XPB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XPB_CLR_A_704	56%	53%	0.155	0.928	0.66	1.13	-	3	2	0	100%	1
4XPB_CLR_A_705	27%	55%	0.218	0.868	0.69	1.04	-	2	0	0	100%	1
4XPG_CLR_A_703	35%	54%	0.243	0.933	0.67	1.1	-	3	0	0	100%	1
4XPF_CLR_A_704	19%	48%	0.296	0.893	0.66	1.34	-	5	0	0	100%	1
4M48_CLR_A_705	19%	55%	0.31	0.907	0.62	1.12	-	5	1	0	100%	1
4XNU_CLR_A_604	1%	53%	0.729	0.878	0.65	1.15	-	3	2	0	100%	1
5IU4_CLR_A_2405	98%	59%	0.055	0.977	0.71	0.86	-	-	1	0	100%	1
5IU7_CLR_A_2405	95%	59%	0.072	0.976	0.75	0.82	-	-	0	0	100%	1
5MZJ_CLR_A_2404	90%	54%	0.078	0.961	0.77	0.99	-	2	0	0	100%	1
5OLZ_CLR_A_1203	89%	53%	0.082	0.96	0.71	1.08	-	3	5	0	100%	1
1LRI_CLR_A_99	88%	37%	0.088	0.965	1.14	1.34	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.